Who
Nikunj Jain
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Sangamo Therapeutics.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Oct 2025
- Last trade
- 25 May 2026
- Last filed
- 27 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 May 2026filed 27 May 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $3341,919 at $0.1743 | filing |
| 25 May 2026filed 27 May 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $3261,919 at $0.17 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Sangamo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $2,4065,119 at $0.47 | filing |
| 25 Feb 2026filed 26 Feb 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $2,4065,119 at $0.47 | filing |
| 24 Feb 2026filed 26 Feb 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $315666 at $0.4725 | filing |
| 24 Feb 2026filed 26 Feb 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $313666 at $0.47 | filing |
| 22 Jan 2026filed 26 Jan 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $3,0777,721 at $0.3985 | filing |
| 22 Jan 2026filed 26 Jan 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $3,0887,721 at $0.40 | filing |
| 24 Nov 2025filed 26 Nov 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $243578 at $0.42 | filing |
| 22 Oct 2025filed 24 Oct 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $4,4276,708 at $0.66 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.